Technical

Technical — Blue Moon Group Holdings (6993.HK)

Blue Moon is a Hong Kong-listed Chinese home care products maker (laundry detergent, hand wash) that IPO'd in December 2020 at HK$14.88 and has since lost 79% of its value. The price is currently testing its 200-day moving average from below — a make-or-break level — after a death cross was confirmed in September 2025. RSI is approaching overbought and the MACD is barely positive: momentum is there, but it is thin.

1. Price Snapshot

2. Full-History Price with 50/200-Day SMA

Price is below the 200-day SMA by 0.1% — essentially at it — after bouncing from the 52-week low of HK$2.50. This is a secular downtrend: from IPO highs of HK$18.50 the stock has fallen 83%, and the most recent death cross (50d crossing below 200d, September 2025) keeps the structural bias bearish.

3. Relative Strength vs Hang Seng & HK Broad Market

All three series rebased to 100 at 16 Dec 2020 (Blue Moon IPO date).

Blue Moon has collapsed to 21 (an 79% loss) while the Hang Seng Index and the broad HK market ETF (EWH) are nearly flat at 98–97. The gap has not narrowed meaningfully. This is not cyclical underperformance — it is a structural de-rating of the business. Any technical buy signal must be weighed against this performance gap: there is no evidence the market is wrong.

4. Momentum — RSI and MACD

Near-term (1–3 month) read: momentum is positive but thinning. RSI has risen from oversold levels and is now at 67.8 — approaching the 70 threshold where rallies historically stall or reverse. The MACD histogram has been positive since late 2025 but registers only +0.016 at the last print: positive, not powerful.

5. Volume and Conviction

Recent volume has been sparse. The September 2025 cluster — three consecutive days of 7–22x average volume — marked a decisive event (likely H1 2025 results), but those spikes preceded the death cross rather than reversing it. The current 22% 1-month rally has not been backed by comparable volume surges, raising the question of whether conviction is following price.

Top volume-spike days:

6. Volatility Regime

Current 30-day realized volatility is 30.8% — at the 25th percentile of the full history, firmly in the "normal" band (p20–p80 = 29–50%). The stock is not pricing in unusual risk at the moment. Historically, vol spikes in this name have coincided with results announcements; the absence of stress now is consistent with the 200-day SMA test being a quiet technical inflection rather than a crisis.

Percentile bands: calm (under 29.2%) · normal (29.2–50.3%) · stressed (above 50.3%)

7. Technical Scorecard and Stance

Net score: −1 (slight bearish lean)

Stance: Bearish on the 3-to-6 month horizon.

The price is testing its 200-day SMA from below in the context of an active death cross. The recent 22% 1-month bounce is real but not validated by volume, and RSI at 67.8 leaves little room for further momentum expansion before hitting overbought territory. Relative performance vs the Hang Seng has been catastrophic since IPO — 79 percentage points of underperformance — and there is no technical evidence of a structural reversal. Volatility is calm, which is constructive but not sufficient to flip the bias. The two levels that matter: a sustained close above HK$3.80 (21% above current, meaningfully through the 200-day SMA) would signal the death cross has been neutralised and invite a move toward the 52-week high at HK$4.33; a close below HK$2.50 (the 52-week low) would confirm the downtrend is reasserting and open a path toward the all-time low of HK$1.71.